We are live on ! Find out more
WGSWW

GeneDx Holdings Warrant

Delisted

WGSWW was delisted on the 21st of July, 2026.

20 hedge funds and large institutions have $50.8K invested in GeneDx Holdings Warrant in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.89% less ownership

Funds ownership: 1.54%0.65% (-0.89%)

5% less funds holding

Funds holding: 2120 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

92% less capital invested

Capital invested by funds: $641K → $50.8K (-$591K)

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
4
Closed
2
Calls
$6K
Puts
Net Calls
+$6K
Net Calls Change
-$4K

WGSWW Hedge Fund Activity: Q2 2023 in Review

20 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q2 2023, worth a combined $50.8K — down 92% from $641K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of WGSWW and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, adding an estimated $83. The largest seller was Difesa Capital Management, exiting entirely with an estimated $14.2K sold.

  • 20 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q2 2023, down from 21 in Q1 2023.
  • Funds reported $50.8K of GeneDx Holdings Warrant stock for Q2 2023, down 92% quarter-over-quarter.
  • 1 fund opened new GeneDx Holdings Warrant positions in Q2 2023 and 2 closed out, a net change of -1 holder.
  • The largest GeneDx Holdings Warrant buyer in Q2 2023 was Morgan Stanley, an estimated $83 added.
  • The largest GeneDx Holdings Warrant seller in Q2 2023 was Difesa Capital Management, an estimated $14.2K sold.

Based on aggregated 13F filings for Q2 2023.